We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00916747
Recruitment Status : Active, not recruiting
First Posted : June 9, 2009
Last Update Posted : February 27, 2023
Merck Sharp & Dohme LLC
Eiger BioPharmaceuticals
Information provided by (Responsible Party):
Monica E. Kleinman, Boston Children's Hospital